Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts

BACKGROUND: Antibody-mediated rejection (AMR) is a major barrier to the long-term function of renal allografts. Platelets and leukocytes, which may be present in red blood cell (RBC) units, express HLA antigens that may increase the risk of AMR by inducing or increasing humoral sensitization to HLA....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transfusion
Autori principali: Bynum, Jennifer P., Zachary, Andrea, Ness, Paul M., Luo, Xun, Bagnasco, Serena, King, Karen E., Segev, Dorry L., Orandi, Babak J., Warren, Daniel S., Fuller, Alice, Ciappi, Ana, Montgomery, Robert, Tobian, Aaron A. R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6131050/
https://ncbi.nlm.nih.gov/pubmed/30171817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.14800
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi